Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib
Kidney Res Clin Pract. 2022;41(4):422-431.   Published online 2022 Mar 29     DOI: https://doi.org/10.23876/j.krcp.21.309
Citations to this article as recorded by Crossref logo
The Role of the L-Arginine–Nitric Oxide Molecular Pathway in Autosomal Dominant Polycystic Kidney Disease
Corina Daniela Ene, Mircea Penescu, Ilinca Nicolae, Cristina Capusa
Journal of Personalized Medicine.2024; 14(3): 299.     CrossRef
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
Yaerim Kim, Seungyeup Han
The Korean Journal of Internal Medicine.2023; 38(3): 322.     CrossRef
Are you ready to accompany autosomal dominant polycystic kidney disease patients in their treatment journey? Real practice for selecting rapid progressors and treatment with tolvaptan
Yeonsoon Jung, Yun Kyu Oh
Kosin Medical Journal.2023; 38(2): 87.     CrossRef
Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology
Tomasz Stompór, Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Michał Nowicki, Leszek Tylicki, Agata Winiarska, Magdalena Krajewska
Journal of Clinical Medicine.2023; 12(16): 5184.     CrossRef
Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
Yaerim Kim, Hayne Cho Park, Hyunjin Ryu, Yong Chul Kim, Curie Ahn, Kyu-Beck Lee, Yeong Hoon Kim, Seungyeup Han, Eun Hui Bae, Kyungjo Jeong, Jungmin Choi, Kook-Hwan Oh, Yun Kyu Oh
Journal of Korean Medical Science.2023;[Epub]     CrossRef
Non-contrast low-dose CT can be used for volumetry of ADPKD
Jaeyeong Yoo, Jin up Kim, Jisu Kim, Sohyun Jeon, Young-jin Song, Kwang-ho Choi, Seok-hyung Kim, Jong-woo Yoon, Hyunsuk Kim
BMC Nephrology.2023;[Epub]     CrossRef
Case report: Genotype-phenotype characteristics of nine novel PKD1 mutations in eight Chinese patients with autosomal dominant polycystic kidney disease
Jing Zhuang, Ailima Aierken, Dilina Yalikun, Jun Zhang, Xiaoqin Wang, Yongfang Ren, Xuefei Tian, Hong Jiang
Frontiers in Medicine.2023;[Epub]     CrossRef
Exploring the clinical and genetical spectrum of ADPKD in Chile to assess ProPKD score as a risk prediction tool
Esperanza Bayyad, Anita Plaza, Jaime Klenner, Patricio Downey, Paulina Salas, Daniela Maragaño, Patricio Herrera, Paula Lehmann, Lily Quiroz, María Jesus Zavala, Karen Orostica, Claudio Flores, Leopoldo Ardiles, Jorge Maturana, Paola Krall
Translational Medicine Communications.2023;[Epub]     CrossRef
Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
Eleftherios Gkekas, Tsz Yau Tiffany Tang, Alan Green, Han Davidson, Rachel Fraser, John A. Sayer, Shalabh Srivastava
Frontiers in Nephrology.2022;[Epub]     CrossRef